Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Nilotinib | 0.031623 | uM | 4 | 2500.00 | 1726.92 | 3310.00 | 3320.50 | 0.9968 | 0.9933 |
| SK-BR-3 | Nilotinib | 3.1623 | uM | 4 | 2500.00 | 1726.92 | 3374.00 | 3320.50 | 1.0161 | 1.0342 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 4 | 2500.00 | 1726.92 | 3906.00 | 3320.50 | 1.1763 | 1.3758 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 4 | 2500.00 | 1726.92 | 3571.00 | 3320.50 | 1.0754 | 1.1603 |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 3349.00 | 3320.50 | 1.0086 | 1.0182 | |
| SK-BR-3 | Etoposide | 0.1 | uM | 4 | 2500.00 | 1726.92 | 3283.00 | 3320.50 | 0.9887 | 0.9761 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 4 | 2500.00 | 1726.92 | 3474.00 | 3320.50 | 1.0462 | 1.0982 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 4 | 2500.00 | 1726.92 | 3212.00 | 3320.50 | 0.9673 | 0.9308 |
| SK-BR-3 | PLX-4720 | 0.31623 | uM | 4 | 2500.00 | 1726.92 | 3490.00 | 3320.50 | 1.0510 | 1.1084 |
| SK-BR-3 | NVP-TAE684 | 0.031623 | uM | 4 | 2500.00 | 1726.92 | 3019.00 | 3320.50 | 0.9092 | 0.8080 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 4 | 2500.00 | 1726.92 | 3546.00 | 3320.50 | 1.0679 | 1.1443 |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 4 | 2500.00 | 1726.92 | 3166.00 | 3320.50 | 0.9535 | 0.9015 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 4 | 2500.00 | 1726.92 | 3296.00 | 3320.50 | 0.9926 | 0.9844 |
| SK-BR-3 | PLX-4720 | 1 | uM | 4 | 2500.00 | 1726.92 | 2853.00 | 3320.50 | 0.8592 | 0.7028 |
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 4 | 2500.00 | 1726.92 | 3342.00 | 3320.50 | 1.0065 | 1.0137 |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 3219.00 | 3320.50 | 0.9694 | 0.9352 | |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 3388.00 | 3320.50 | 1.0203 | 1.0431 | |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 2888.00 | 3320.50 | 0.8698 | 0.7249 | |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 3175.00 | 3320.50 | 0.9562 | 0.9072 | |
| SK-BR-3 | Etoposide | 0.01 | uM | 4 | 2500.00 | 1726.92 | 3355.00 | 3320.50 | 1.0104 | 1.0220 |
| SK-BR-3 | Etoposide | 0.31623 | uM | 4 | 2500.00 | 1726.92 | 2073.00 | 3320.50 | 0.6243 | 0.2137 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 4 | 2500.00 | 1726.92 | 3562.00 | 3320.50 | 1.0727 | 1.1545 |
| SK-BR-3 | Nilotinib | 0.01 | uM | 4 | 2500.00 | 1726.92 | 3617.00 | 3320.50 | 1.0893 | 1.1898 |
| SK-BR-3 | Nilotinib | 0.1 | uM | 4 | 2500.00 | 1726.92 | 3074.00 | 3320.50 | 0.9258 | 0.8430 |
| SK-BR-3 | Etoposide | 19.9526 | uM | 4 | 2500.00 | 1726.92 | 1151.00 | 3320.50 | 0.3466 | -0.3496 |